1482
C. Olsson et al. / Tetrahedron: Asymmetry 19 (2008) 1476–1483
325.1031; (C15H17O3F3 requires C, 59.60; H, 5.67. Found: C, 59.49;
H, 5.61.)
J = 10.6 Hz), 1.81 (1H, dAB, JAB = 10.6 Hz); 13C NMR (100 MHz, pyri-
dine-d5) d 37.8, 40.2, 44.6, 46.1, 52.2, 79.4, 122.3, 125.5, 126.1,
126.3, 129.0, 129.3, 129.7, 132.7, 144.8, 217.3 (one peak hidden
by solvent); HRMS (FAB+, direct inlet) [M]: calcd for C17H16O2:
252.1150. Found: 252.1156; (C17H16O2 requires C, 80.93; H, 6.39.
Found: C, 80.79; H, 6.43.)
4.9. (+)-(1R,2R,4S,6S)-2-(2-Hydroxy-phenyl)-bicyclo[2.2.2]-
octane-2,6-diol (+)-20
2-Bromophenol (0.73 mL, 6.3 mmol) was added to a solution
of n-BuLi (2.5 M in hexane, 5.0 mL, 12.6 mmol) in diethyl ether
(15 mL) at ꢀ78 °C. The colourless mixture was stirred at rt for
3.5 h, then cooled to ꢀ78 °C followed by the addition of (ꢀ)-17
(0.30 g, 2.1 mmol) dissolved in diethyl ether (20 mL). After 3 h,
satd aqueous NH4Cl was added to the yellow solution. The aque-
ous phase was saturated with NaCl and then extracted with
diethyl ether. The combined organic phases were washed with
brine followed by drying over Na2SO4 and removal of the solvent
at reduced pressure. The residue was column chromatographed
(SiO2, heptane–EtOAc 80:20) to give (+)-20 (0.17 g, 35%) of >99%
ee as a very viscous oil; TLC Rf 0.49 (heptane–EtOAc, 1:1);
4.12. (ꢀ)-(1S,4S,5S)-5-Hydroxy-5-(2-methoxy-phenyl)-
bicyclo[2.2.1]heptan-2-one (ꢀ)-11
The title compound was synthesized from (ꢀ)-8 (2.33 g,
10 mmol) following the same procedure as for (ꢀ)-12. The
resulting solid was column chromatographed (SiO2, heptane–
EtOAc, 70:30) to give (ꢀ)-11 (1.98 g, 85%) of 96% ee as a white
solid. Recrystallization from heptane–EtOAc gave 99% ee; TLC
Rf 0.42 (heptane–EtOAc, 1:1);
½
a 2D0
ꢃ
¼ ꢀ64 (c 1, CHCl3); mp
112.9–113.4 °C; IR (KBr) 3535, 3507, 1748 cmꢀ1
;
1H NMR
(400 MHz, pyridine-d5) d 7.42–7.44 (1H, m), 7.31–7.35 (1H, m),
6.99–7.06 (2H, m), 5.62 (1H, s), 3.70 (3H, s), 3.24 (1H, m),
3.17–3.22 (1H, dd, J = 17.5, 3.5 Hz), 2.60–2.61 (1H, m), 2.43–
2.48 (1H, m), 2.13–2.23 (2H, m), 1.69–1.76 (1H, m); 13C NMR
(100 MHz, pyridine-d5) d 37.5, 39.9, 44.1, 44.9, 52.3, 55.7, 78.4,
112.7, 121.1, 125.6, 129.2, 158.6, 217.3 (one peak hidden by sol-
½
a 2D0
ꢃ
¼ þ38 (c 0.56, CHCl3); IR (NaCl) 3308 (very broad) cmꢀ1
;
1H NMR (400 MHz, C6D6) d 0.60–0.69 (1H, m), 0.76–0.83 (1H,
m), 1.00–1.13 (2H, m), 1.25–1.31 (1H, m), 1.48–1.52 (1H, m),
1.59–1.67 (1H, m), 1.77 (1H, dt, J = 12.4, 2.8 Hz), 1.99–2.01 (1H,
m), 2.42 (1H, dt, J = 15.2, 2.8 Hz), 3.44–3.49 (1H, m), 6.15 (1H,
s), 6.76–6.80 (1H, m), 6.95–6.97 (1H, m), 7.10–7.14 (1H, m),
7.20–7.22 (1H, m), 10.29 (1H, s); 13C NMR (100 MHz, C6D6) d
20.4, 22.5, 26.1, 37.8, 39.7, 42.8, 71.7, 80.4, 119.0, 119.1, 127.4,
129.3, 129.8, 158.8; HRMS (FAB+) [M+Na]: calcd for C14H18O3Na:
257.1154. Found: 257.1154; (C14H18O3 requires C, 71.77; H, 7.74.
Found: C, 71.83; H, 7.80.)
vent); HRMS (ES+) [MꢀOH]: calcd for
C14H15O2: 215.1072.
Found: 215.1067; (C14H16O3 requires C, 72.39; H, 6.94. Found:
C, 72.42; H, 7.06.)
4.13. (ꢀ)-(1S,2S,4S,5S)-2-Phenyl-bicyclo[2.2.1]heptane-2,5-diol
(ꢀ)-15
4.10. (ꢀ)-(1S,4S,5S)-5-Hydroxy-5-phenyl-bicyclo[2.2.1]heptan-
2-one (ꢀ)-12
NaBH4 (0.056 g, 1.5 mmol) was added in portions at 0 °C to a
solution of (ꢀ)-12 (0.1 g, 0.5 mmol) in MeOH (10 mL). The resulting
solution was stirred at 0 °C for 15 min then water (5 mL) was
added. The aqueous phase was extracted with EtOAc, the combined
organic phases were washed with brine, dried (Na2SO4) and the
solvent was removed under reduced pressure. The residue was col-
umn chromatographed (SiO2, i-PrOH–CH2Cl2, 10:90) to give (ꢀ)-15
(0.090 g, 88%) of >99% ee as a white solid. TLC Rf 0.19 (heptane–
Compound (ꢀ)-9 (0.50 g, 2.4 mmol), NMO (0.56 g, 4.8 mmol),
MS 4 Å and TPAP (0.042 g, 0.12 mmol) were mixed in CH2Cl2
(50 mL). The resulting mixture was stirred at rt for 1.5 h, then
diluted with EtOAc and filtered through Celite/silica (rinsed with
EtOAc). The solvent was removed at reduced pressure and the
resulting oil was filtered through a pad of SiO2 (heptane–EtOAc,
1:1) to give (ꢀ)-12 (0.44 g, 91%) of 94% ee as a white solid.
Recrystallization from toluene gave >99% ee; TLC Rf 0.44 (hep-
EtOAc, 1:1); ½a 2D0
ꢃ
¼ ꢀ23 (c 0.6, EtOH); mp 71–72 °C; IR (KBr)
3457, 3377, 3296 cmꢀ1
;
1H NMR (400 MHz, pyridine-d5) d 7.83–
7.84 (2H, m), 7.41–7.45 (2H, m), 7.27–7.31 (1H, m), 4.58–4.63
(1H, m), 2.93 (1H, dd, J = 13.2, 3.0 Hz), 2.68 (1H, dt, J = 12.8,
3.3 Hz), 2.61–2.62 (1H, m), 2.47 (1H, m), 2.34 (1H, ddAB, J = 13.2,
4.9 Hz), 1.97–2.04 (1H, m), 1.69 (1H, dmAB, JAB = 10.7 Hz), 1.41
(1H, dmAB, JAB = 10.4 Hz); 13C NMR (100 MHz, pyridine-d5) d 33.4,
37.7, 37.7, 44.8, 49.7, 72.5, 80.4, 127.0, 127.4, 128.8 (one peak hid-
den by solvent); HRMS (ES+) [M+H]: calcd for C13H16O2: 204.1150.
Found: 204.1169; (C13H16O2 requires C, 76.44; H, 7.90. Found: C,
76.40; H, 7.81.)
tane–EtOAc, 1:1); ½a D20
ꢃ
¼ ꢀ56 (c 1.1, CHCl3); mp 101–103 °C; IR
(KBr) 3365, 1720 cmꢀ1
;
1H NMR (400 MHz, pyridine-d5)
d
7.75–7.78 (2H, m), 7.42–7.45 (2H, m), 7.30–7.34 (1H, m), 7.18
(1H, s), 3.23–3.29 (1H, dd, J = 17.5, 4.3 Hz), 2.95 (1H, m), 2.63–
2.70 (2H, m), 2.09–2.19 (2H, m), 1.82–1.85 (1H, m), 1.66–1.69
(1H, m); 13C NMR (100 MHz, pyridine-d5) d 38.4, 41.3, 44.1, 48.5,
53.2, 79.9, 128.0, 128.4, 129.9, 218.2 (one peak hidden by solvent);
HRMS (ES+) [M+H]: calcd for
C13H15O2: 203.1072. Found:
203.1069; (C13H14O2 requires C, 77.20; H, 6.98. Found: C, 77.33;
H, 6.91.)
4.14. (ꢀ)-(1S,2S,4S,5S)-2-(2-Methoxy-phenyl)-bicyclo[2.2.1]-
heptane-2,5-diol (ꢀ)-14
4.11. (ꢀ)-(1S,4S,5S)-5-Hydroxy-5-(1-naphthyl)-bicyclo[2.2.1]-
heptan-2-one (ꢀ)-13
The title compound was synthesized from (ꢀ)-11 (0.050 g,
0.22 mmol) following the same procedure as for (ꢀ)-15. The crude
product (ꢀ)-14 (0.051 g, 98%) of >99% ee (white solid) was pure
enough to be used without further purification; TLC Rf 0.13
The title compound was synthesized from (ꢀ)-10 (0.30 g,
1.2 mmol) following the same procedure as for (ꢀ)-12. The result-
ing solid was column chromatographed (SiO2, heptane–EtOAc, 1:1)
to give (ꢀ)-13 (0.27 g, 83%) of 94% ee as a white solid. Recrystalli-
zation from heptane–EtOAc gave >99% ee; TLC Rf 0.46 (heptane–
(heptane–EtOAc, 1:1);
½
a 2D0
ꢃ
¼ ꢀ28 (c 0.55, EtOH); mp 114–
117 °C; IR (KBr) 3545, 3465 cmꢀ1
;
1H NMR (400 MHz, pyridine-
d5) d 7.46–7.42 (1H, m), 7.32–7.28 (1H, m), 7.04–6.98 (1H, m),
5.98 (1H, br s), 4.62–4.58 (1H, m), 3.70 (3H, s), 3.01 (1H, dd,
J = 13.6, 2.9 Hz), 2.84 (1H, d, J = 4.7 Hz), 2.68 (1H, dt, J = 12.7,
3.6 Hz), 2.39 (1H, m), 2.21 (1H, dd, J = 13.6, 4.9 Hz), 2.05–1.97
EtOAc, 1:1); ½a 2D0
ꢃ
¼ ꢀ119 (c 1.15, t-BuOMe); mp 144–147 °C; IR
(KBr) 3447, 3071, 1728 cmꢀ1
;
1H NMR (400 MHz, pyridine-d5) d
9.03 (1H, d, J = 8.4 Hz), 7.96–7.99 (1H, m), 7.88 (1H, d, J = 8.1 Hz),
7.51–7.61 (3H, m), 7.46 (1H, t, J = 7.7 Hz), 7.36 (1H, s), 3.44 (1H,
d, J = 3.4 Hz), 3.37 (1H, dd, J = 17.6, 4.1 Hz), 2.63 (1H, br s), 2.51
(2H, m), 2.26 (1H, dd, J = 17.5, 4.7 Hz), 1.86–1.90 (1H, dm,
(1H, m), 1.62 (1H, dmAB
, JAB = 10.2 Hz), 1.46 (1H, dmAB,
JAB = 10.4 Hz); 13C NMR (100 MHz, pyridine-d5) d 32.5, 37.6, 37.9,
44.6, 47.2, 55.7, 72.8, 80.2, 121.0, 123.3, 126.2, 128.6, 137.8,